pharma · Pyruvate Kinase Deficiency · Sickle Cell Disease · AGIO
Agios Netherlands
Agios Netherlands B.V.
Agios Netherlands clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
CAMBRIDGE, MA, NL HQ
1978 Founded
20 Employees
Public company Type
AGIO · NYSE Ticker
Company details
- Status
- Public
- HQ
- CAMBRIDGE, MA, NL
- Founded
- 1978
- Employees
- 20
- Programs
- 45
- Drugs
- 15
- Patents
- 93
Agios Netherlands projects
1 ClinicalTrials.gov programs sponsored by Agios Netherlands.
Agios Netherlands has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Agios Netherlands have?
1 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.